Somerset Healthcare Investment Advisors has made its first investment from its third fund by acquiring Cyrix Healthcare, a medical devices manufacturer based in India, aimed at capitalizing on the growing healthcare market.

Target Information

Cyrix Healthcare is an innovative company specializing in the development of advanced medical devices aimed at enhancing patient care. With a strong focus on technology integration, Cyrix Healthcare has established itself as a significant player in the medical device sector, delivering solutions that improve diagnosis and treatment outcomes across various healthcare settings.

The company prides itself on its R&D capabilities, as well as its commitment to quality and regulatory compliance, ensuring that its products meet the highest standards of safety and efficacy. This approach has enabled Cyrix Healthcare to build a solid reputation and expand its market reach, positioning it well for future growth.

Industry Overview

The medical device industry in India is experiencing robust growth, fueled by increasing healthcare expenditure and a rising demand for advanced medical technologies. India’

View Source

Similar Deals

BC Investment (Bain Capital) Emcure Pharmaceuticals Limited

2025

Other Private Equity Generic Pharmaceuticals India
ADV Partners Dr. Agarwal’s Healthcare Limited

Other Private Equity Hospitals, Clinics & Primary Care Services India
India Life Sciences Fund Fleming Laboratories

Other Private Equity Generic Pharmaceuticals India
Kedaara Capital Vijaya Diagnostic Centre Private Limited

Other Private Equity Medical & Diagnostic Laboratories India
WhiteOak Capital, Creador, Siguler Guff La Renon Healthcare

Other Private Equity Pharmaceuticals (NEC) India
Quadria Capital Maxivision Eye Hospital

Other Private Equity Hospitals, Clinics & Primary Care Services India

Somerset

invested in

Cyrix Healthcare

in 2024

in a Other Private Equity deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert